Toward Stability Enhancement of NTS(1)R-Targeted Radioligands: Structural Interventions on [(99m)Tc]Tc-DT1

por Kanellopoulos, Panagiotis, Nock, Berthold A., Krenning, Eric P., Maina, Theodosia
Publicado 2023

Optimizing the Profile of [(99m)Tc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors

por Kanellopoulos, Panagiotis, Nock, Berthold A., Krenning, Eric P., Maina, Theodosia
Publicado 2020

Side-Chain Modified [(99m)Tc]Tc-DT1 Mimics: A Comparative Study in NTS(1)R-Positive Models

por Kanellopoulos, Panagiotis, Nock, Berthold A., Rouchota, Maritina, Loudos, George, Krenning, Eric P., Maina, Theodosia
Publicado 2023

Reduction of (68)Ge activity containing liquid waste from (68)Ga PET chemistry in nuclear medicine and radiopharmacy by solidification

por de Blois, Erik, Chan, Ho Sze, Roy, Kamalika, Krenning, Eric P., Breeman, Wouter A. P.
Publicado 2010

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

por Kanellopoulos, Panagiotis, Kaloudi, Aikaterini, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2020

Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11—first estimates for clinical translation

por Kaloudi, Aikaterini, Nock, Berthold A., Lymperis, Emmanouil, Valkema, Roelf, Krenning, Eric P., de Jong, Marion, Maina, Theodosia
Publicado 2016

Comparing Gly(11)/dAla(11)-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the (111)In-SB3/(111)In-SB4 Radiotracer Pair

por Lymperis, Emmanouil, Kaloudi, Aikaterini, Kanellopoulos, Panagiotis, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2019

[(99m)Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

por Kanellopoulos, Panagiotis, Lymperis, Emmanouil, Kaloudi, Aikaterini, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2020

A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling

por Hasan, Djo, Shono, Atsuko, van Kalken, Coenraad K., van der Spek, Peter J., Krenning, Eric P., Kotani, Toru
Publicado 2021

One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [(99m)Tc]Tc-DB4 and [(111)In]In-SG4 in Mice Treated with Entresto

por Kanellopoulos, Panagiotis, Kaloudi, Aikaterini, Rouchota, Maritina, Loudos, George, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2020

Report on short-term side effects of treatments with (177)Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

por van Essen, Martijn, Krenning, Eric P., Kam, Boen L., de Herder, Wouter W., van Aken, Maarten O., Kwekkeboom, Dik J.
Publicado 2008

Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK(2)R Cancer Theranostic Agents: A Preclinical Study

por Nock, Berthold A., Kanellopoulos, Panagiotis, Chepurny, Oleg G., Rouchota, Maritina, Loudos, George, Holz, George G., Krenning, Eric P., Maina, Theodosia
Publicado 2022

[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

por Tatsi, Aikaterini, Maina, Theodosia, Cescato, Renzo, Waser, Beatrice, Krenning, Eric P, de Jong, Marion, Cordopatis, Paul, Reubi, Jean Claude, Nock, Berthold A
Publicado 2012

Localization of (99m)Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses

por Kaloudi, Aikaterini, Lymperis, Emmanouil, Kanellopoulos, Panagiotis, Waser, Beatrice, de Jong, Marion, Krenning, Eric P., Reubi, Jean Claude, Nock, Berthold A., Maina, Theodosia
Publicado 2019

Euro-Collins Solution Versus Uw-Solution for Long-Term Liver Preservation in the Isolated Rat-Liver Perfusion Model

por Toom, René Den, De Jong, Marion, Krenning, Eric P., Hoek, Hans J. Van Der, Kate, Fiebo J. W. Ten, Hennemann, Georg, Terpstra, Onno T.
Publicado 1991

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours

por Melis, Marleen, Bijster, Magda, de Visser, Monique, Konijnenberg, Mark W., de Swart, Jan, Rolleman, Edgar J., Boerman, Otto C., Krenning, Eric P., de Jong, Marion
Publicado 2009

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

por de Keizer, Bart, van Aken, Maarten O., Feelders, Richard A., de Herder, Wouter W., Kam, Boen L. R., van Essen, Martijn, Krenning, Eric P., Kwekkeboom, Dik J.
Publicado 2008

Effects of therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate on endocrine function

por Teunissen, Jaap J. M., Krenning, Eric P., de Jong, Frank H., de Rijke, Yolanda B., Feelders, Richard A., van Aken, Maarten O., de Herder, Wouter W., Kwekkeboom, Dik J.
Publicado 2009

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

por Schroeder, Rogier P. J., Müller, Cristina, Reneman, Suzanne, Melis, Marleen L., Breeman, Wout A. P., de Blois, Erik, Bangma, Chris H., Krenning, Eric P., van Weerden, Wytske M., de Jong, Marion
Publicado 2010

Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

por Bergsma, Hendrik, Konijnenberg, Mark W., van der Zwan, Wouter A., Kam, Boen L. R., Teunissen, Jaap J. M., Kooij, Peter P., Mauff, Katya A. L., Krenning, Eric P., Kwekkeboom, Dik J.
Publicado 2016